About Ching-Yun Hsu
Form D filings for Escalante Bioscience in 2024 list Ching-Yun Hsu as chief executive officer and director.
Ching-Yun Hsu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ching-Yun Hsu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ching-Yun Hsu works with at each company, as listed on that company's latest Form D.
Escalante Bioscience, Inc. · Form D, May 17, 2024